Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Clinical trial NCT00387400 · COMPLETED
Trial details
- NCT number
- NCT00387400
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-20
- Primary completion
- 2010-09-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.